Alaunos Therapeutics (TCRT) Revenue (2011 - 2025)
Alaunos Therapeutics (TCRT) reported Revenue of $3000.0 for Q4 2025, down 25.0% on a YoY basis from $4000.0 in Q4 2024, and up 50.0% quarter-over-quarter from $2000.0 in Q1 2025.
Alaunos Therapeutics (TCRT) Revenue (2011 - 2025) Analysis & Trends
Alaunos Therapeutics has reported Revenue for 13 years, with the latest figure at $3000.0 in Q4 2025.
- For the quarter ending Q4 2025, Revenue fell 25.0% year-over-year to $3000.0; the trailing twelve-month figure through Mar 2026 stood at $3000.0 (down 70.0% YoY), and the FY2025 full-year result was $5000.0, down 50.0% from the prior year.
- Revenue for Q4 2025 stood at $3000.0, up from $2000.0 in the prior quarter.
- The five-year high for Revenue was $2.9 million in Q3 2022, with the low at $1000.0 in Q4 2023.
- Historically, Revenue has averaged $303727.3 across 5 years, with a median of $4000.0 in 2023.
- Annual changes were most pronounced in 2022 — Revenue surged 631.41% — and 2023, when it plunged 90.91%.
- Alaunos Therapeutics' Revenue stood at $2000.0 in 2021, then soared by 450.0% to $11000.0 in 2022, then sank by 90.91% to $1000.0 in 2023, then jumped by 300.0% to $4000.0 in 2024, then retreated by 25.0% to $3000.0 in 2025.
- The last three Revenue figures came in at $3000.0 (Q4 2025), $2000.0 (Q1 2025), and $4000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | 2.91 Mn |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 398,000.00 |
| Mar 31, 2018 | 146,000.00 |
| Dec 31, 2017 | 1.60 Mn |
| Sep 30, 2017 | 1.60 Mn |
| Jun 30, 2017 | 1.60 Mn |
| Mar 31, 2017 | 1.60 Mn |
| Dec 31, 2016 | 1.60 Mn |
| Sep 30, 2016 | 1.60 Mn |
| Jun 30, 2016 | 1.70 Mn |
| Mar 31, 2016 | 1.97 Mn |